Findings

What do systematic reviews say?

3,006 questions · 3,171 findings · 607 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 411 · 13%GRADE not reported 153 · 4.8%Very low 968 · 30.5%Low 897 · 28.3%Moderate 589 · 18.6%High 153 · 4.8%

Preoperative education vs usual care

Quality of Life: SF‐36 (physical component) · patients with knee replacement surgery

1 finding from 1 review

Preoperative education for hip or knee replacement 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 109 participants
Low

Massage + phonophoresis vs phonophoresis alone

Function Visual analog function index Scale from 0 to 100 (higher is better) · patients with extensor carpi radialis tendinitis

1 finding from 1 review

Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Massage + ultrasound and placebo ointment vs ultrasound + placebo ointment only

Function Visual analog function index Scale from 0 to 100 (higher is better) · patients with extensor carpi radialis tendinitis

1 finding from 1 review

Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Primary comparison for continuous passive motion (CPM) vs no CPM

Function Various validated function scales. · hospitalised patients who have undergone knee replacement surgery

1 finding from 1 review

Continuous passive motion following total knee arthroplasty in people with arthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 405 participants
Moderate

Primary comparison for continuous passive motion (CPM) vs no CPM

Quality of life SF‐12. Scale from: 0 to 100 (higher score better). · hospitalised patients who have undergone knee replacement surgery

1 finding from 1 review

Continuous passive motion following total knee arthroplasty in people with arthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 156 participants
Moderate

CANNABIS REDUCTION: ADJUNCT PSYCHOLOGICAL THERAPY vs treatment

Cannabis use · patients with SCHIZOPHRENIA AND CANNABIS USE

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Moderate

CANNABIS REDUCTION: ANTIPSYCHOTIC 'A' vs ANTIPSYCHOTIC 'B' for

**Mental state: Obsessive–Compulsive Drug Use Scale (OCDUS) (short‐term, higher=bad) ‐ short term Scale from: 0 to 44. · patients with schizophrenia

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Moderate

Cannabidiol vs AMISULPRIDE

Cannabis use · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabidiol vs AMISULPRIDE

Mental state: PANSS total (high = bad) ‐ medium term ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Mental state · patients with SCHIZOPHRENIA AND CANNABIS USE

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate

Summary of findings: needle acupuncture vs sham

Quality of life (QOLIE‐89) (1‐ to 3‐month periods) · adults with intractable epilepsy

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Low

Summary of findings: needle acupuncture vs valproate

Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · participants with epilepsy (one included study only recruited children with absence epilepsy while another included study recruited both…

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Low

Summary of findings: catgut implantation at acupoints plus antiepileptic drugs vs antiepileptic drugs alone

Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · people with epilepsy

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 120 participants
Low

Summary of findings: catgut implantation at acupoints vs valproate

Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · participants with generalised epilepsy

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Low

Summary of findings: needle acupuncture plus valproate vs valproate

Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · participants with generalised epilepsy

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 90 participants
Low

Acupuncture vs STANDARD DOSE ANTIPSYCHOTICS

Mental state: psychopathology Total endpoint data, BPRS (higher score = worse, scale from: 0‐126) · patients with schizophrenia

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs RISPERIDONE

Global state: Response ‐ proxy outcome ‐ mental state: 1. General ‐ average score (Brief Psychiatric Rating Scale by over 24 weeks · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 570 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs CLOZAPINE

Global state: Response ‐ proxy outcome ‐ mental state: 1. General ‐ average score (Brief Psychiatric Rating Scale by over 24 weeks · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 426 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs QUETIAPINE

Mental state: 2. Positive symptoms ‐ average endpoint score PANSS positive subscore · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 583 participants
Very low

Methotrexate vs placebo

Maintenance of clinical remission · Participants with Crohn's disease in remission

Methotrexate probably leads to higher proportion of patients maintaining clinical remission (high dose… compared with placebo (moderate certainty).

1 finding from 1 review

Methotrexate for maintenance of remission in Crohn's disease 2014 · Cochrane Headline outcomes only
RR 1.67 [1.05, 2.67]
1 study · 76 participants
Moderate